Wednesday, April 12, 2017

Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 6

If you are unable to see the message below, click here to view.

Volume 42, Issue 6 (May 2017)

In this issue
Original Articles

Also new

Follow NPP on Facebook Facebook

Follow NPP on Twitter Twitter

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Open for Submissions

An interdisciplinary journal dedicated to publishing high-quality open research relevant to all aspects of schizophrenia and psychosis.

Explore the benefits of submitting your next research article.



Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders

G Sanacora, H Heimer, D Hartman, S J Mathew, M Frye, C Nemeroff and R Robinson Beale

Neuropsychopharmacology 2017 42: 1179-1181; advance online publication, October 12, 2016; 10.1038/npp.2016.193

Full Text

Original Articles


Genetic and Modeling Approaches Reveal Distinct Components of Impulsive Behavior

Katherine M Nautiyal, Melanie M Wall, Shuai Wang, Valerie M Magalong, Susanne E Ahmari, Peter D Balsam, Carlos Blanco and René Hen

Neuropsychopharmacology 2017 42: 1182-1191; advance online publication, January 18, 2017; 10.1038/npp.2016.277

Abstract | Full Text

Minimum Electric Field Exposure for Seizure Induction with Electroconvulsive Therapy and Magnetic Seizure Therapy

Won H Lee, Sarah H Lisanby, Andrew F Laine and Angel V Peterchev

Neuropsychopharmacology 2017 42: 1192-1200; advance online publication, January 25, 2017; 10.1038/npp.2016.276

Abstract | Full Text

Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities

Meng Li, Liliana Ramona Demenescu, Lejla Colic, Coraline Danielle Metzger, Hans-Jochen Heinze, Johann Steiner, Oliver Speck, Anna Fejtova, Giacomo Salvadore and Martin Walter

Neuropsychopharmacology 2017 42: 1201-1209; advance online publication, October 19, 2016; 10.1038/npp.2016.184

Abstract | Full Text

Ketamine Treatment and Global Brain Connectivity in Major Depression

Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang, Dan V Iosifescu, Dennis S Charney and James W Murrough

Neuropsychopharmacology 2017 42: 1210-1219; advance online publication, October 12, 2016; 10.1038/npp.2016.186

Abstract | Full Text

Ketamine Corrects Stress-Induced Cognitive Dysfunction through JAK2/STAT3 Signaling in the Orbitofrontal Cortex

Michael S Patton, Daniel J Lodge, David A Morilak and Milena Girotti

Neuropsychopharmacology 2017 42: 1220-1230; advance online publication, November 9, 2016; 10.1038/npp.2016.236

Abstract | Full Text

GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine

Rong-Jian Liu, Catharine Duman, Taro Kato, Brendan Hare, Dora Lopresto, Eunyoung Bang, Jeffery Burgdorf, Joseph Moskal, Jane Taylor, George Aghajanian and Ronald S Duman

Neuropsychopharmacology 2017 42: 1231-1242; advance online publication, October 19, 2016; 10.1038/npp.2016.202

Abstract | Full Text

Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB/CBP-Dependent Manner

Morgan S Bridi, Joshua D Hawk, Snehajyoti Chatterjee, Stephen Safe and Ted Abel

Neuropsychopharmacology 2017 42: 1243-1253; advance online publication, December 7, 2016; 10.1038/npp.2016.253

Abstract | Full Text

Impact of Stress and Glucocorticoids on Schema-Based Learning

Lisa Marieke Kluen, Patricia Nixon, Agorastos Agorastos, Klaus Wiedemann and Lars Schwabe

Neuropsychopharmacology 2017 42: 1254-1261; advance online publication, December 14, 2016; 10.1038/npp.2016.256

Abstract | Full Text

Stress Induces a Shift Towards Striatum-Dependent Stimulus-Response Learning via the Mineralocorticoid Receptor

Susanne Vogel, Floris Klumpers, Tobias Navarro Schröder, Krista T Oplaat, Harm J Krugers, Melly S Oitzl, Marian Joëls, Christian F Doeller and Guillén Fernández

Neuropsychopharmacology 2017 42: 1262-1271; advance online publication, December 21, 2016; 10.1038/npp.2016.262

Abstract | Full Text

GABAb Receptor Mediates Opposing Adaptations of GABA Release From Two Types of Prefrontal Interneurons After Observational Fear

Lei Liu, Wataru Ito and Alexei Morozov

Neuropsychopharmacology 2017 42: 1272-1283; advance online publication, January 4, 2017; 10.1038/npp.2016.273

Abstract | Full Text

Context and Auditory Fear are Differentially Regulated by HDAC3 Activity in the Lateral and Basal Subnuclei of the Amygdala

Janine L Kwapis, Yasaman Alaghband, Alberto J López, André O White, Rianne R Campbell, Richard T Dang, Diane Rhee, Ashley V Tran, Allison E Carl, Dina P Matheos and Marcelo A Wood

Neuropsychopharmacology 2017 42: 1284-1294; advance online publication, January 4, 2017; 10.1038/npp.2016.274

Abstract | Full Text

Sex Differences in μ-Opioid Receptor Regulation of the Rat Locus Coeruleus and Their Cognitive Consequences OPEN

Herminio M Guajardo, Kevin Snyder, Andrew Ho and Rita J Valentino

Neuropsychopharmacology 2017 42: 1295-1304; advance online publication, December 14, 2016; 10.1038/npp.2016.252

Abstract | Full Text

Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition

Michael D Schwartz, Sarah W Black, Simon P Fisher, Jeremiah B Palmerston, Stephen R Morairty, Marius C Hoener and Thomas S Kilduff

Neuropsychopharmacology 2017 42: 1305-1314; advance online publication, October 26, 2016; 10.1038/npp.2016.216

Abstract | Full Text

Chemogenetic Activation of Midbrain Dopamine Neurons Affects Attention, but not Impulsivity, in the Five-Choice Serial Reaction Time Task in Rats

Linde Boekhoudt, Elisa S Voets, Jacques P Flores-Dourojeanni, Mieneke CM Luijendijk, Louk JMJ Vanderschuren and Roger AH Adan

Neuropsychopharmacology 2017 42: 1315-1325; advance online publication, November 16, 2016; 10.1038/npp.2016.235

Abstract | Full Text

Methylphenidate Enhances Early-Stage Sensory Processing and Rodent Performance of a Visual Signal Detection Task

Rachel L Navarra, Brian D Clark, Andrew T Gargiulo and Barry D Waterhouse

Neuropsychopharmacology 2017 42: 1326-1337; advance online publication, January 4, 2017; 10.1038/npp.2016.267

Abstract | Full Text

Neurophysiological Characterization of Attentional Performance Dysfunction in Schizophrenia Patients in a Reverse-Translated Task

Jared W Young, Andrew W Bismark, Yinming Sun, Wendy Zhang, Meghan McIlwain, Ibrahim Grootendorst and Gregory A Light

Neuropsychopharmacology 2017 42: 1338-1348; advance online publication, February 8, 2017; 10.1038/npp.2016.268

Abstract | Full Text

Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes

Emilie I Petit, Zuzanna Michalak, Rachel Cox, Colm M P O’Tuathaigh, Niamh Clarke, Orna Tighe, Konrad Talbot, Derek Blake, Josephine Joel, Alexander Shaw, Steven A Sheardown, Alastair D Morrison, Stephen Wilson, Ellen M Shapland, David C Henshall, James N Kew, Brian P Kirby and John L Waddington

Neuropsychopharmacology 2017 42: 1349-1360; advance online publication, January 25, 2017; 10.1038/npp.2016.282

Abstract | Full Text

Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study OPEN

New Fei Ho, Daphne J Holt, Mike Cheung, Juan Eugenio Iglesias, Alex Goh, Mingyuan Wang, Joseph KW Lim, Joshua de Souza, Joann S Poh, Yuen Mei See, Alison R Adcock, Stephen J Wood, Michael WL Chee, Jimmy Lee and Juan Zhou

Neuropsychopharmacology 2017 42: 1361-1370; advance online publication, February 1, 2017; 10.1038/npp.2017.5

Abstract | Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

nature publishing group

No comments: